Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2025 18:20 ET | Source: Bleichmar Fonti & Auld

MLTX BREAKING NEWS: BFA Law is Investigating MoonLake Immunotherapeutics (NASDAQ: MLTX) for Securities Fraud after Stock Drops 90% on Drug Trial Results, Investors Urged to Contact the Firm

MoonLake Immunotherapeutics investors that lost money on their investment are encouraged to contact BFA Law about their rights.